Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions

Internal Medicine

Answer 4
  1. Gabapentin is usually given at a dose of 600 mg 3 times daily to patients with postherpetic neuralgia. Gabapentin is FDA-approved for postherpetic neuralgia, and clinical trials show efficacy typically at a dosage of 600 mg 3 times daily. Gabapentin is safe for use in patients with cardiac disease, has a similar adverse effect frequency compared with tricyclic antidepressant agents, and is somewhat more expensive than the other agents used to treat postherpetic neuralgia.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj